| Characteristics |
Statistics |
| Age (years) |
54 ± 31.5 (40-82) |
| Gender |
|
| Male |
26 (81.3%) |
| Female |
6 (18.7%) |
| Number of metastatic nodules in lungs at treatment |
|
| 3 |
2 (6.2%) |
| 3-6 |
11 (34.4%) |
| ≥6 |
19 (59.4%) |
| Metastatic tumors in right or/and left lungs |
|
| Right |
11 (34.4%) |
| Left |
8 (25.0%) |
| Both |
13 (40.6%) |
| Primary HCC therapy |
|
| Surgical resection |
22 (68.7%) |
| Transcatheter arterial chemoembolisation |
7 (21.9%) |
| Percutaneous ethanol injection |
2 (6.3%) |
| Cryoablation |
1 (3.1%) |
|